Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOMAC-E2 vs drospirenone/ethinyl estradiol oral contraceptive trial
2005-005304-16Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nomegestrol acetate + estradiol (2 arms), sponsored by Organon & Co. Primary endpoint: Pearl Index for contraceptive efficacy. Started Mar 2006; status: completed.
02
Drugs
nomegestrol acetate + estradiol
Beyond the preview
Go deeper on 2005-005304-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005304-16.